Exact Mass: 286.174

Exact Mass Matches: 286.174

Found 80 metabolites which its exact mass value is equals to given mass value 286.174, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Methyl-4-dimethylallyltryptophan

N-Methyl-4-dimethylallyltryptophan

C17H22N2O2 (286.1681)


   

10-alpha-methoxy-9,10-dihydrolysergol

[(4R)-2-methoxy-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-4-yl]methanol

C17H22N2O2 (286.1681)


10-alpha-methoxy-9,10-dihydrolysergol is a metabolite of nicergoline. Nicergoline (marketed under the trade name Sermion) is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It has been found to increase mental agility and enhance clarity and perception. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs. (Wikipedia)

   

Thonzylamine

N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyrimidin-2-amine

C16H22N4O (286.1794)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Thonzylamine is a first-generation ethylenediamine H1-antihistamine. Thonzylamine is an orally active H1 histamine receptor antagonist, exhibits good antihistaminic and antianaphylactic properties. Thonzylamine can be used for the research of hypersensitivity diseases, nasal congestion, allergic conjunctivitis and other allergic diseases[1][2].

   
   
   

4-DMAL-L-abnine

4-Methylallyl-L-abrine

C17H22N2O2 (286.1681)


   
   

Malkanguniol

Malkanguniol

C15H26O5 (286.178)


   

1,10:4,5-Diepoxy-6,11-germacranediol-(1R,4R,5R,6R,10R)-form-14-Hydroyx

1,10:4,5-Diepoxy-6,11-germacranediol-(1R,4R,5R,6R,10R)-form-14-Hydroyx

C15H26O5 (286.178)


   

cytospolide M

cytospolide M

C15H26O5 (286.178)


   

cytospolide Q

cytospolide Q

C15H26O5 (286.178)


   

cytospolide F

cytospolide F

C15H26O5 (286.178)


   
   

(2alpha,4beta,6alpha,8alpha,9alpha,10alpha)-8,9-Epoxy-2,4,6,10-daucanetetrol

(2alpha,4beta,6alpha,8alpha,9alpha,10alpha)-8,9-Epoxy-2,4,6,10-daucanetetrol

C15H26O5 (286.178)


   

Methyl 2-methyl-4-[2,3,8,8a-tetrahydro-1-methylpyrrolo[2,3-b]indol-3a(1H)-yl]-2-butenoate

Methyl 2-methyl-4-[2,3,8,8a-tetrahydro-1-methylpyrrolo[2,3-b]indol-3a(1H)-yl]-2-butenoate

C17H22N2O2 (286.1681)


   
   

2-dec-9-enyl-3-hydroxypentanedioic acid

NCGC00380897-01!2-dec-9-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

2-dec-4-enyl-3-hydroxypentanedioic acid

NCGC00381422-01!2-dec-4-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

Ergoline-8-methanol, 10-methoxy-6-methyl-, (8b)-

Ergoline-8-methanol, 10-methoxy-6-methyl-, (8b)-

C17H22N2O2 (286.1681)


   

methyl (E)-2-methyl-4-((3aS)-1-methyl-2,3,8,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-enoate

methyl (E)-2-methyl-4-((3aS)-1-methyl-2,3,8,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-yl)but-2-enoate

C17H22N2O2 (286.1681)


   

1-Boc-4-(4-Cyanophenyl)piperidine

1-Boc-4-(4-Cyanophenyl)piperidine

C17H22N2O2 (286.1681)


   

2-(1-PROPYL-4-PIPERIDINYL)-1H-BENZIMIDAZOLE-7-CARBOXAMIDE

1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)-

C16H22N4O (286.1794)


   

1,5-bis(4-aminophenoxy)pentane

1,5-bis(4-aminophenoxy)pentane

C17H22N2O2 (286.1681)


   

4-[3-(4-aminophenoxy)-2,2-dimethylpropoxy]aniline

4-[3-(4-aminophenoxy)-2,2-dimethylpropoxy]aniline

C17H22N2O2 (286.1681)


   

ETHYL 1-BENZYL-3-(TERT-BUTYL)-1H-PYRAZOLE-5-CARBOXYLATE

ETHYL 1-BENZYL-3-(TERT-BUTYL)-1H-PYRAZOLE-5-CARBOXYLATE

C17H22N2O2 (286.1681)


   

1,4-Bis(2-phenylethyl)benzene,

1,4-Bis(2-phenylethyl)benzene,

C22H22 (286.1721)


   

[3-(Adamantan-1-yl)-4-methoxyphenyl]boronic acid

[3-(Adamantan-1-yl)-4-methoxyphenyl]boronic acid

C17H23BO3 (286.174)


   

3-PYRROLIDIN-2-YL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-PYRROLIDIN-2-YL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C17H22N2O2 (286.1681)


   

8-Benzyl-2-ethyl-2,8-diazaspiro[4.5]decane-1,3-dione

8-Benzyl-2-ethyl-2,8-diazaspiro[4.5]decane-1,3-dione

C17H22N2O2 (286.1681)


   

Linogliride

Linogliride

C16H22N4O (286.1794)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

tert-butyl 4-cyano-4-phenylpiperidine-1-carboxylate

tert-butyl 4-cyano-4-phenylpiperidine-1-carboxylate

C17H22N2O2 (286.1681)


   

2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE

2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE

C12H23BN2O5 (286.17)


   

spiro-(adamantane-2,9-fluorene)

spiro-(adamantane-2,9-fluorene)

C22H22 (286.1721)


   

[4-(1-adamantyl)-2-nitrophenyl]methylamine

[4-(1-adamantyl)-2-nitrophenyl]methylamine

C17H22N2O2 (286.1681)


   

3,4-dimethyl-2,6-dinitro-N-(2,2,3,4,4-pentadeuteriopentan-3-yl)aniline

3,4-dimethyl-2,6-dinitro-N-(2,2,3,4,4-pentadeuteriopentan-3-yl)aniline

C13H14D5N3O4 (286.1689)


   

3-(TERT-BUTYL)-1-(3-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE

3-(TERT-BUTYL)-1-(3-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE

C16H22N4O (286.1794)


   

1-(NAPHTHALEN-2-YLOXY)-3-PIPERAZIN-1-YL-PROPAN-2-OL

1-(NAPHTHALEN-2-YLOXY)-3-PIPERAZIN-1-YL-PROPAN-2-OL

C17H22N2O2 (286.1681)


   

Fenpipalone

Fenpipalone

C17H22N2O2 (286.1681)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

(2S)-2-amino-N-(4-methoxynaphthalen-2-yl)-4-methylpentanamide

(2S)-2-amino-N-(4-methoxynaphthalen-2-yl)-4-methylpentanamide

C17H22N2O2 (286.1681)


   

(3S)-1-Cyclohexyl-5-oxo-N-phenylpyrrolidine-3-carboxamide

(3S)-1-Cyclohexyl-5-oxo-N-phenylpyrrolidine-3-carboxamide

C17H22N2O2 (286.1681)


   

Thonzylamine

Thonzylamine

C16H22N4O (286.1794)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Thonzylamine is an orally active H1 histamine receptor antagonist, exhibits good antihistaminic and antianaphylactic properties. Thonzylamine can be used for the research of hypersensitivity diseases, nasal congestion, allergic conjunctivitis and other allergic diseases[1][2].

   

(4R)-4-[(1R)-2,4-dihydroxy-1,4-dimethylcyclohexyl]-4-methyl-1-oxaspiro[2.4]heptane-6,7-diol

(4R)-4-[(1R)-2,4-dihydroxy-1,4-dimethylcyclohexyl]-4-methyl-1-oxaspiro[2.4]heptane-6,7-diol

C15H26O5 (286.178)


   

10-alpha-methoxy-9,10-dihydrolysergol

10-alpha-methoxy-9,10-dihydrolysergol

C17H22N2O2 (286.1681)


   

Peribysin J

Peribysin J

C15H26O5 (286.178)


   

1-(1-Benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol

1-(1-Benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol

C17H22N2O2 (286.1681)


   

(2S)-2-(methylazaniumyl)-3-[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]propanoate

(2S)-2-(methylazaniumyl)-3-[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]propanoate

C17H22N2O2 (286.1681)


   

1-(3,4-Dimethylphenyl)-3-piperidin-1-ylpyrrolidine-2,5-dione

1-(3,4-Dimethylphenyl)-3-piperidin-1-ylpyrrolidine-2,5-dione

C17H22N2O2 (286.1681)


   

N-[(3,4-dimethoxyphenyl)methyl]-N-methyl-2-(2-pyridinyl)ethanamine

N-[(3,4-dimethoxyphenyl)methyl]-N-methyl-2-(2-pyridinyl)ethanamine

C17H22N2O2 (286.1681)


   

2-[(E)-dec-4-enyl]-3-hydroxypentanedioic acid

2-[(E)-dec-4-enyl]-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

2-Dec-9-enyl-3-hydroxypentanedioic acid

2-Dec-9-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

4-(3-methylbut-2-enyl)-L-abrine

N-Methyl-4-dimethylallyltryptophan

C17H22N2O2 (286.1681)


A methy-amino acid that is L-tryptophan substituted at the N(alpha)-position by a methyl group and at the 4-position by a 3-methylbut-2-enyl group.

   

4-(3-methylbut-2-enyl)-L-abrine zwitterion

4-(3-methylbut-2-enyl)-L-abrine zwitterion

C17H22N2O2 (286.1681)


An amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of 4-(3-methylbut-2-enyl)-L-abrine.

   

Methylbutenyl-abrine

Methylbutenyl-abrine

C17H22N2O2 (286.1681)


   

1-(dimethylamino)-13-ethenyl-11-(hydroxymethyl)-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

1-(dimethylamino)-13-ethenyl-11-(hydroxymethyl)-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C17H22N2O2 (286.1681)


   

2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

2-methyl-n-[(2s)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

C17H22N2O2 (286.1681)


   

4,9-dihydroxy-10-(4-hydroxypentyl)-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

4,9-dihydroxy-10-(4-hydroxypentyl)-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

C15H26O5 (286.178)


   

(1s,2r,5r,6s,7r,8r)-6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

(1s,2r,5r,6s,7r,8r)-6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

C15H26O5 (286.178)


   

(2s,2'r,3s,4r,5's)-3-hydroxy-5'-[(1r)-1-hydroxyhexyl]-4-methyl-[2,2'-bioxolan]-5-one

(2s,2'r,3s,4r,5's)-3-hydroxy-5'-[(1r)-1-hydroxyhexyl]-4-methyl-[2,2'-bioxolan]-5-one

C15H26O5 (286.178)


   

1-[(2r,3r,3ar,6s,7r,7as)-2,6,7-trihydroxy-3,6-dimethyl-hexahydro-1-benzofuran-2-yl]-3-methylbutan-1-one

1-[(2r,3r,3ar,6s,7r,7as)-2,6,7-trihydroxy-3,6-dimethyl-hexahydro-1-benzofuran-2-yl]-3-methylbutan-1-one

C15H26O5 (286.178)


   

(9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

(9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

[C18H24NO2]+ (286.1807)


   

(1s,2r,3s,4ar,6r,8s,8ar)-2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

(1s,2r,3s,4ar,6r,8s,8ar)-2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

C15H26O5 (286.178)


   

n-{[2-(2-methylbut-3-en-2-yl)-4-oxo-2,3-dihydro-1h-quinolin-3-yl]methyl}ethanimidic acid

n-{[2-(2-methylbut-3-en-2-yl)-4-oxo-2,3-dihydro-1h-quinolin-3-yl]methyl}ethanimidic acid

C17H22N2O2 (286.1681)


   

6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

C15H26O5 (286.178)


   

methyl (2e)-4-[(3as,8as)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-enoate

methyl (2e)-4-[(3as,8as)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl]-2-methylbut-2-enoate

C17H22N2O2 (286.1681)


   

(3s,9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

(3s,9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

[C18H24NO2]+ (286.1807)


   

(1s,2r,5s,6s,7r,8r,9s)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

(1s,2r,5s,6s,7r,8r,9s)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

C15H26O5 (286.178)


   

2-(methylamino)-3-[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]propanoic acid

2-(methylamino)-3-[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]propanoic acid

C17H22N2O2 (286.1681)


   

methyl 2-methyl-4-{1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl}but-2-enoate

methyl 2-methyl-4-{1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-3a-yl}but-2-enoate

C17H22N2O2 (286.1681)


   

(3r,4r,5e,9s,10r)-4,9-dihydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

(3r,4r,5e,9s,10r)-4,9-dihydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

C15H26O5 (286.178)


   

3-hydroxy-5'-(1-hydroxyhexyl)-4-methyl-[2,2'-bioxolan]-5-one

3-hydroxy-5'-(1-hydroxyhexyl)-4-methyl-[2,2'-bioxolan]-5-one

C15H26O5 (286.178)


   

(1r,9r,13r)-1-(dimethylamino)-13-ethenyl-11-(hydroxymethyl)-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

(1r,9r,13r)-1-(dimethylamino)-13-ethenyl-11-(hydroxymethyl)-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C17H22N2O2 (286.1681)


   

(2s)-2-(methylamino)-3-[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]propanoic acid

(2s)-2-(methylamino)-3-[4-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]propanoic acid

C17H22N2O2 (286.1681)


   

2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]propanimidic acid

C17H22N2O2 (286.1681)


   

(2z)-2-(8-hydroxydecyl)pent-2-enedioic acid

(2z)-2-(8-hydroxydecyl)pent-2-enedioic acid

C15H26O5 (286.178)


   

2-(8-hydroxydecyl)pent-2-enedioic acid

2-(8-hydroxydecyl)pent-2-enedioic acid

C15H26O5 (286.178)


   

n-{[(2s,3r)-2-(2-methylbut-3-en-2-yl)-4-oxo-2,3-dihydro-1h-quinolin-3-yl]methyl}ethanimidic acid

n-{[(2s,3r)-2-(2-methylbut-3-en-2-yl)-4-oxo-2,3-dihydro-1h-quinolin-3-yl]methyl}ethanimidic acid

C17H22N2O2 (286.1681)


   

2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

C15H26O5 (286.178)


   

6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

C15H26O5 (286.178)